These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 29037897)

  • 1. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucus-penetrating dendritic mesoporous silica nanoparticle loading drug nanocrystal clusters to enhance permeation and intestinal absorption.
    Zhou W; Li B; Min R; Zhang Z; Huang G; Chen Y; Shen B; Zheng Q; Yue P
    Biomater Sci; 2023 Jan; 11(3):1013-1030. PubMed ID: 36545798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides.
    Tan X; Zhang Y; Wang Q; Ren T; Gou J; Guo W; Yin T; He H; Zhang Y; Tang X
    Biomater Sci; 2019 Jun; 7(7):2934-2950. PubMed ID: 31094367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-functionalized mesoporous carbon nanoparticles on overcoming multiple barriers and improving oral bioavailability of Probucol.
    Lu H; Yang G; Ran F; Gao T; Sun C; Zhao Q; Wang S
    Carbohydr Polym; 2020 Feb; 229():115508. PubMed ID: 31826471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers.
    Gao Y; He Y; Zhang H; Zhang Y; Gao T; Wang JH; Wang S
    J Colloid Interface Sci; 2021 Jan; 582(Pt A):364-375. PubMed ID: 32861041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
    Florek J; Caillard R; Kleitz F
    Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
    Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
    Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.
    Attar ES; Jayakumar S; Devarajan PV
    AAPS PharmSciTech; 2024 May; 25(5):113. PubMed ID: 38750336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carriers for hydrophobic drug molecules: lipid-coated hollow mesoporous silica particles, and the influence of shape and size on encapsulation efficiency.
    Iqbal S; Schneider TK; Truong TT; Ulrich-Müller R; Nguyen PH; Ilyas S; Mathur S
    Nanoscale; 2024 Jun; 16(23):11274-11289. PubMed ID: 38787696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility.
    Hu B; Wang J; Li J; Li S; Li H
    Int J Nanomedicine; 2020; 15():601-618. PubMed ID: 32099354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.